Read + Share
Holder AM, Wargo JA, Ross MI. Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with
Resectable Metastatic Melanoma. Ann Surg Oncol 2023 Aug 19. doi: 10.1245/s10434-023-14133.
PMID: 37597079
|
 |
|
Holder AM, Wargo JA, Ross MI. Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with
Resectable Metastatic Melanoma. Ann Surg Oncol 2023 Aug 19. doi: 10.1245/s10434-023-14133.
PMID: 37597079
|
|
|
|